Mark A. Glickman - 15 Oct 2021 Form 3 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Chief Business Officer
Signature
/S/ Mark A. Glickman
Issuer symbol
TXMD
Transactions as of
15 Oct 2021
Net transactions value
$0
Form type
3
Filing time
15 Oct 2021, 17:15:24 UTC
Next filing
28 Mar 2022
SEC
View on sec.gov

No securities are beneficially owned.